Genetic linkage and association studies of type I diabetes: Challenges and rewards

Diabetologia

Volumn 45, Issue 1, 2002, Pages 21-35

  Field, L L ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Aetiology; Association; Genetics; Linkage; Susceptibility genes; Type I diabetes

Indexed keywords

GENE MAPPING; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC MARKER; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW;

CHROMOSOME MAPPING; DIABETES MELLITUS, TYPE 1; FAMILY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE (GENETICS); MAJOR HISTOCOMPATIBILITY COMPLEX; RISK ASSESSMENT; TWIN STUDIES;

EID: 0036164731     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s125-002-8241-7     Document Type: Review

References (141)

1. Genetic heterogeneity, modes of inheritance and risk estimates for a joint study of Caucasians with insulin-dependent diabetes mellitus
2. Gene dosage and susceptibility to insulin-dependent diabetes
3. Assessing the role of HLA-linked and unlinked determinants of disease
4. Differences in risk of insulin-dependent diabetes in offspring of diabetic mothers and diabetic fathers
5. Decreased risk of type I diabetes in offspring of mothers who acquire diabetes during adrenarchy
6. Evidence for importance of gender and birth cohort for risk of IDDM in offspring of IDDM parents
7. Prediction on type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies
8. Perinatal autoimmunity in offspring of diabetic parents. The German Multicenter BABY-DIAB study: Detection of humoral immune responses to islet antigens in early childhood
9. Determinants of IDDM and perinatal mortality in children of diabetic mothers
10. Diabetes in identical twins
11. The significance of the concordance rate for Type I (insulin-dependent) diabetes in identical twins
12. North American twins with IDDM. Genetic, etiological, and clinical significance of disease concordance according to age, zygosity, and the interval after diagnosis in first twin
13. Concordance rates of insulin dependent diabetes mellitus: A population based study of young Danish twins
14. Value of antibodies to islet protein tryosine phosphatase-like molecule in predicting type I diabetes
15. Heterogeneity of Type I diabetes: Analysis of monozygotic twins in Great Britain and the United States
16. Evidence that the age at diagnosis of IDDM is genetically determined
17. Latent autoimmune diabetes mellitus in adults (LADA): The role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency
18. Crucial points at diagnosis. Type 2 diabetes or slow type 1 diabetes
19. Newly diagnosed latent autoimmune diabetes in adults (LADA) is associated with low level glutamate decarboxylase (GAD65) and IA-2 autoantibodies. Diabetes Incidence Study in Sweden (DISS)
20. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies
21. Role of viruses in type I diabetes
22. Antibodies against bovine albumin and other diabetes markers in French children
23. Diabetes mellitus and autoimmunity in patients with the congenital rubella syndrome
24. Several different enterovirus serotypes can be associated with prediabetic autoimmune episodes and onset of overt IDDM
25. Maternal enteroviral infection during pregnancy as a risk factor for childhood IDDM. A population-based case-control study
26. Islet cell antibody seroconversion in children is temporally associated with enterovirus infections
27. Autoantigens IA-2 and GAD in Type I (insulin-dependent) diabetes
28. Prediction of IDDM in the general population: Strategies based on combinations of autoantibody markers
29. Islet autoantibodies in cord blood from children who developed Type I (insulin-dependent) diabetes mellitus before 15 years of age
30. Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: The 2-year analysis of the German BABYDIAB Study
31. Glutamate decarboxylase-, insulin-, and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children
32. Genetic, immunological, and metabolic determinants of risk for type 1 diabetes mellitus in families
33. Population based study of prevalence of islet cell autoantibodies in monozygotic and dizygotic Danish twin pairs with insulin dependent diabetes mellitus
34. Genetic determination of islet cell autoimmunity in monozygotic twin, dizygotic twin, and non-twin siblings of patients with type 1 diabetes: Prospective twin study
35. Value of insulin autoantibodies as serum markers for insulin-dependent diabetes mellitus
36. Late progression to diabetes and evidence for chronic beta-cell autoimmunity in identical twins of patients with type I diabetes
37. Genetic dissection of complex traits: Guidelines for interpreting and reporting linkage results
38. Linkage strategies for genetically complex traits. II. The power of affected relative pairs
39. HLA disease associations: A model for the study of complex human genetic disorders
40. HLA-DR effects in a large German IDDM dataset
41. Genes predisposing to IDDM in multiplex families
42. Mapping disease genes: Family based association studies
43. Transmission distortion test for linkage: The insulin gene and susceptibility in insulin-dependent diabetes mellitus
44. An extended transmission/disequilibrium test (TDT) for multi-allele marker loci
45. The TDT and other family-based tests for linkage disequilibrium and association
46. The British Diabetic Association - Warren repository
47. Family cell lines available for research
48. Histocompatibility (HL-A) antigens, lymphocytotoxic antibodies and tissue antibodies in patients with diabetes mellitus
49. HL-A antigens and diabetes mellitus
50. Letter: HL-A antigens and diabetes mellitus
51. Specific genomic markers for the HLA-DQ subregion discriminate between DR4 + insulin-dependent diabetes and DR4 + seropositive juvenile rheumatoid arthritis
52. HLA-DQB gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus
53. A diabetes susceptibility HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles
54. Identification of susceptibility loci for insulin-dependent diabetes mellitus by transracial gene mapping
55. A combination of HLA-DQ beta Asp57-negative and HLA DQ alpha Arg52 confers susceptibility to insulin-dependent diabetes mellitus
56. A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes mellitus
57. HLA and Insulin gene associations with IDDM
58. A locus on chromosome 15q26 (IDDM3) produces susceptibility to insulin-dependent diabetes mellitus
59. Affected sibpair mapping of a novel susceptibility gene to insulin-dependent diabetes mellitus (IDDM8) on chromosome 6q25-q27
60. Linkage of type I diabetes to 15q26 (IDDM3) in the Danish population
61. A genome-wide search for human type 1 diabetes susceptibility genes
62. Genetic mapping of a susceptibility locus for insulin-dependent diabetes mellitus on chromosome 11q
63. Confirmation of three susceptibility genes to insulin-dependent diabetes mellitus: IDDM4, IDDM5, and IDDM8
64. Fine mapping of the diabetes-susceptibility locus, IDDM4, on chromosome 11q13
65. Fine mapping of the type 1 diabetes locus (IDDM4) on chromosome 11q and evaluation of two candidate genes (FADD and GALN) by affected sibpair and linkage-disequilibrium analyses
66. Saturation multi-point linkage mapping of chromosome 6 q in type 1 diabetes
67. Close genetic linkage between diabetes mellitus and kidd blood group
68. Evidence by allelic association-dependent methods for a type 1 diabetes polygene (IDDM6) on chromosome 18q21
69. Suggstive evidence for association of human chromosome 18q12-q21 and its orthologue on rat and mouse chromosome 18 with several autoimmune diseases
70. The HOXD8 locus (2q31) is linked to type I diabetes: Interaction with chromosome 6 and 11 disease susceptibility genes
71. Linkage disequilibrium mapping of a type 1 diabetes susceptibility gene (IDDM7) to chromosome 2q31-q33
72. Physical and genetic mapping of IDDM8 on chromosome 6q27
73. A search for type 1 diabetes susceptibility genes in families from the United Kingdom
74. Evidence for a type 1 diabetes susceptibility locus (IDDM10) on human chromosome 10p11-q11
75. Susceptibility to insulin-dependent diabetes mellitus maps to a locus (IDDM11) on chromosome 14q24.3-q31
76. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes
77. Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups
78. CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus
79. CTLA-4 gene polymorphism is associated with predisposition to IDDM in a population from central Poland
80. Genetic and physical mapping of a type 1 diabetes susceptibility gene (IDDM12) to a 100-kb phagemid artificial chromosome clone containing D2S72-CTLA4-D2S105 on chromosome 2q33
81. Markers on distal chromosome 2q linked to insulin-dependent diabetes mellitus
82. Evidence of a non-MHC susceptibility locus in type I diabetes linked to HLA on chromosome 6
83. A second-generation screen of the human genome for susceptibility to insulin-dependent diabetes mellitus
84. The immunoglobulin heavy-chain variable region in insulin-dependent diabetes mellitus: Affected-sib-pair analysis and association studies
85. Type 1 diabetes
86. Evidence for oligogenic inheritance of type 1 diabetes in a large Bedouin Arab family
87. Linkage disequilibrium of a type 1 diabetes susceptibility locus with a regulatory IL12B allele
88. A male-female bias in type 1 diabetes and linkage to chromosome Xp in MHC HLA-DR3-positive patients
89. Linkage and association between insulin-dependent diabetes mellitus (IDDM) susceptibility and markers near the glucokinase gene on chromosome 7
90. Association of polymorphism in the interferon gamma gene with IDDM
91. A CA repeat polymorphism of the IFN-ã gene is associated with susceptibility to type 1 diabetes
92. HLA susceptibility to type 1 diabetes: Methods and mechanisms
93. The genetics of susceptibility to insulin-dependent diabetes:possible new markers
94. The association of MHC with autoimmune diseases: Understanding the pathogenesis of autoimmune diabetes
95. The predisposition to type 1 diabetes linked to the human leukocyte antigen complex includes at least one non-class II gene
96. Protection from insulin-dependent diabetes mellitus is linked to a peptide transporter gene
97. Association of LMP2 and LMP7 genes within the major histocompatibility complex with insulin-dependent diabetes mellitus: Population and family studies
98. Linkage disequilibrium between TAP2 variants and HLA class II alleles; no primary association between TAP2 variants and insulin-dependent diabetes mellitus
99. Insulin-dependent diabetes mellitus and the major histocompatibility complex peptide transporters TAP1 and TAP2: No association in a population with a high disease incidence
100. Family study of linkage disequilibrium between TAP2 transporter and HLA class II genes. Absence of TAP2 contribution to association with insulin-dependent diabetes mellitus
101. No independent associations of LMP2 and LMP7 polymorphisms with susceptibility to develop IDDM
102. The affected sib method. IV. Sib trios
103. The human insulin gene linked polymorphic region exhibits an altered DNA structure
104. Structure-function correlations of the insulin-linked polymorphic region
105. Regulation of insulin gene expression by the IDDM associated, insulin locus haplotype
106. Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus
107. The minisatellite in the diabetes susceptibility locus IDDM2 regulates insulin transcription
108. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus
109. The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes
110. The insulin gene and susceptibility to IDDM
111. Non-HLA region genes in insulin dependent diabetes mellitus
112. Insulin-IGF2 region on chromosome 11p encodes a gene implicated in HLA-DR4-dependent diabetes susceptibility
113. The future of genetic studies of complex human diseases
114. Locus for antiviral enzyme 2′,5′oligoadenylate synthetase (OAS) on chromosome 12q24 influences predisposition to Type 1 diabetes
115. Significant association between interferon regulatory factor 2 (IRF2) gene and Type I diabetes
116. Genetic dissection of complex traits
117. Genetic dissection of complex traits
118. True and false positive peaks in genomewide scans: Applications of length-based sampling to linkage mapping
119. The sequence and gene characterization of a 400-kb candidate region for IDDM4 on chromosome 11q13
120. The length of the CTLA-4 microsatellite (AT)n-repeat affects the risk for type 1 diabetes
121. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4
122. Two-locus maximum lod score analysis of a multifactorial trait: Joint consideration of IDDM2 and IDDM4 with IDDM1 in type 1 diabetes
123. Association of distal chromosome 2q with IDDM in Japanese subjects
124. Unravelling a complex trait: The genetics of insulin-dependent diabetes mellitus
125. Multilocus linkage tests based on affected relative pairs
126. Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases
127. Comparative genetics of type 1 diabetes and autoimmune disease: Common loci, common pathways?
128. An autosomal screen for genes that predispose to celiac disease in the western counties of Ireland
129. Linkage analysis of candidate regions for coeliac disease genes
130. Evidence for a new Graves disease susceptibility locus at chromosome 18q21
131. Linkage of rheumatoid arthritis to insulin-dependent diabetes mellitus loci: Evidence supporting a hypothesis for the existence of common autoimmune susceptibility loci
132. CTLA-4 gene polymorphism is associated with predisposition to coeliac disease
133. The CTLA4/CD28 gene region on chromosome 2q33 confers susceptibility to celiac disease in a way possibly distinct from that of type 1 diabetes and other chronic inflammatory disorders
134. CTLA4 gene polymorphism confers susceptibility to Graves' disease in Japanese
135. CTLA4 promotor and exon 1 dimorphisms in multiple sclerosis
136. CTLA4 polymorphisms in Spanish patients with rheumatoid arthritis
137. CTLA4 codon 17 dimorphism in patients with rheumatoid arthritis
138. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22
139. Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus
140. Lupus susceptibility genes on chromosome 1